These biodesigned fibers are the first of their kind but they are not yet accessible to most of us. As with many new technology innovations, they often start out very expensive in highly limited supply and, as the technology scales over a period of time, costs come down and availability increases. So while we’re starting to see a few products in the hands of consumers, we’re really at the start of a long journey into biofabrication that will be measured in decades, not months.
What is the biggest barrier at the moment in making biofabrication more ‘mainstream’? Is mainstream even a goal? And if so, how to deal with potential consumers bias in relation to working with living materials as a raw material?
Again, there are multiple technologies making up the field of biofabrication, so there’s no single answer to that question. In general, biofabricated products require many years of R&D, followed by pilots and finally commercial scale-up which can take tens, if not hundreds of millions of dollars. So more investment coming into the field is one requirement. As early investors start to see returns from successfully launched consumer products, many more will want in and so the market for these new technologies will grow.
All the entrepreneurs in our network are seeking to ultimately achieve scale on an order that can service the needs of mass markets. That’s the way to have true impact on a planetary level and for your shareholders.